Risk–benefit analysis of COVID-19 vaccines — a neurological perspective

Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk–benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Colleen L., Galea, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687148/
https://www.ncbi.nlm.nih.gov/pubmed/34931027
http://dx.doi.org/10.1038/s41582-021-00606-5
Descripción
Sumario:Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk–benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors to inform decision-making and support the global vaccination effort.

Ejemplares similares